ReviewFrontiers in medicine2025

HIF-2α inhibitors in clear cell renal cell carcinoma: a clinical pharmacy perspective on lipid metabolism, therapeutic management, and resistance strategies.

Dongmei Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.